Patents by Inventor Su Yan

Su Yan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180127503
    Abstract: The invention relates to antibodies, and in particular, to antibodies exhibiting specificity for Receptor tyrosine kinase-like Orphan Receptors (ROR), and to uses thereof for example in the treatment of cancer. The invention extends to polynucleotide and polypeptide sequences encoding the antibodies, and therapeutic uses thereof, and to diagnostic kits comprising these molecules. The invention also extends to antibody-drug conjugates and to uses thereof in therapy.
    Type: Application
    Filed: March 10, 2016
    Publication date: May 10, 2018
    Inventors: Cheng LIU, Su YAN, Pei WANG, Nai-Kong CHEUNG, Hongfen GUO, Ming CHENG
  • Publication number: 20180121443
    Abstract: A data handling system enables the unsupervised creation of an information extraction dictionary by expanding upon a word or phrase included within an expansion query. Prior to receiving the expansion query, the data handling system performs an unsupervised learning of an information corpus which includes text to assign a corpus vector to each word and phrase of the text. After the expansion query, the data handling system compares the expansion query to the corpus vectors. The data handling system ranks the corpus vectors by similarity to the expansion query and provides a ranked list of words or phrases associated with the ranked corpus vectors. The ranked list may be subsequently utilized as the information extraction dictionary.
    Type: Application
    Filed: November 3, 2016
    Publication date: May 3, 2018
    Inventors: Sheng Hua Bao, Su Yan
  • Publication number: 20180121444
    Abstract: A data handling system enables the unsupervised creation of an information extraction dictionary by expanding upon a word or phrase included within an expansion query. Prior to receiving the expansion query, the data handling system performs an unsupervised learning of an information corpus which includes text to assign a corpus vector to each word and phrase of the text. After the expansion query, the data handling system compares the expansion query to the corpus vectors. The data handling system ranks the corpus vectors by similarity to the expansion query and provides a ranked list of words or phrases associated with the ranked corpus vectors. The ranked list may be subsequently utilized as the information extraction dictionary.
    Type: Application
    Filed: November 3, 2016
    Publication date: May 3, 2018
    Inventors: Sheng Hua Bao, Su Yan
  • Publication number: 20180085457
    Abstract: The present application provides antibody-TCR chimeric constructs comprising an antibody moiety that specifically binds to a target antigen fused to a TCRM capable of recruiting at least one TCR-associated signaling module. Also provided are methods of making and using these constructs.
    Type: Application
    Filed: December 1, 2017
    Publication date: March 29, 2018
    Inventors: Jingwei LU, Zhiyuan YANG, Cheng LIU, Hong LIU, Yiyang XU, Su YAN, Vivien Wai-Fan CHAN, Lucas HORAN
  • Patent number: 9899186
    Abstract: A charged-particle beam microscope is provided for imaging a sample. The microscope has a vacuum chamber to maintain a low-pressure environment. A stage is provided to hold a sample in the vacuum chamber. The microscope has a compact evaporator in the vacuum chamber to evaporate and deposit a coating onto a surface of the sample. The microscope also has a charged-particle beam column is provided to direct a charged-particle beam onto the coating on the surface of the sample. The charged-particle beam column includes a charged-particle beam source to generate a charged-particle beam and charged-particle beam optics to converge the charged-particle beam onto the sample. A detector is provided to detect charged-particle radiation emanating from the coating on the surface of the sample to generate an image. A controller analyzes the detected charged-particle radiation to generate an image of the sample.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: February 20, 2018
    Assignee: Mochii, Inc.
    Inventors: Christopher Su-Yan Own, Matthew Francis Murfitt
  • Publication number: 20180009892
    Abstract: The invention relates to antibodies, and in particular, to antibodies exhibiting specificity for Receptor tyrosine kinase-like Orphan Receptors (ROR), and to uses thereof, for example in the treatment of cancer. The invention extends to polynucleotide and polypeptide sequences encoding the antibodies, and therapeutic uses thereof, and to diagnostic kits comprising these molecules. The invention also extends to antibody-drug conjugates and to uses thereof in therapy.
    Type: Application
    Filed: July 19, 2017
    Publication date: January 11, 2018
    Inventors: CHENG LIU, YIYANG XU, HONG LIU, SU YAN, JINGYI XIANG, PEI WANG
  • Publication number: 20170364594
    Abstract: A set of documents is parsed. Members of the set of documents include a set of text elements and a set of visual elements. A text content stream based on the set of text elements and a visual content stream based on the set of visual elements are produced. For respective documents, a set of respective visual element summarizations is built from the visual content stream. Each visual summarization includes a text description of a respective visual element in the respective document. A holistic index is created by indexing the text content from the text content stream and the text descriptions of the visual elements in a single search index. The indexing uses a set of semantic relationships between the text content from the text content stream and the textual descriptions of the visual elements. A user interface allows a user to selectively search text content and visual content.
    Type: Application
    Filed: June 15, 2016
    Publication date: December 21, 2017
    Inventors: Ying Chen, Ioana Roxana Stanoi, Su Yan, Mo Yu
  • Publication number: 20170088630
    Abstract: The present invention provides antigen binding proteins that specifically bind to Wilms' tumor protein (WT1), including humanized, chimeric and fully human antibodies against WT1, antibody fragments, chimeric antigen receptors (CARs), fusion proteins, and conjugates thereof. The antigen binding proteins and antibodies bind to HLA-A0201-restricted WT1 peptide. Such antibodies, fragments, fusion proteins and conjugates thereof are useful for the treatment of WT1 associated cancers, including for example, breast cancer, ovarian cancer, prostate cancer, chronic myelocytic leukemia, multiple myeloma, acute lymphoblastic leukemia (ALL), acute myeloid/myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). In more particular embodiments, the anti-WT1/A antibodies may comprise one or more framework region amino acid substitutions designed to improve protein stability, antibody binding and/or expression levels.
    Type: Application
    Filed: November 30, 2016
    Publication date: March 30, 2017
    Applicants: MEMORIAL SLOAN KETTERING CANCER CENTER, EUREKA THERAPEUTICS, INC.
    Inventors: David Scheinberg, Tao Dao, Cheng Liu, Su Yan
  • Patent number: 9564291
    Abstract: A charged-particle beam microscope is provided for imaging a sample. The microscope has a stage to hold a sample and a charged-particle beam column to direct a charged-particle beam onto the sample. The charged-particle beam column includes a charged-particle beam source to generate a charged-particle beam, and charged-particle beam optics to converge the charged-particle beam onto the sample. The microscope also has a light beam column to direct a light beam onto the sample. The light beam column includes a light beam source to generate a light beam, and light-beam optics to converge the light beam onto the sample. One or more detectors are provided to detect charged-particle and light radiation emanating from the sample to generate an image. A controller to analyze the detected charged-particle radiation and detected light radiation to generate an image of the sample.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: February 7, 2017
    Assignee: Mochii, Inc.
    Inventors: Christopher Su-Yan Own, Matthew Francis Murfitt
  • Patent number: 9540448
    Abstract: The present invention provides antigen binding proteins that specifically bind to Wilms' tumor protein (WT1), including humanized, chimeric and fully human antibodies against WT1, antibody fragments, chimeric antigen receptors (CARs), fusion proteins, and conjugates thereof. The antigen binding proteins and antibodies bind to HLA-A0201-restricted WT1 peptide. Such antibodies, fragments, fusion proteins and conjugates thereof are useful for the treatment of WT1 associated cancers, including for example, breast cancer, ovarian cancer, prostate cancer, chronic myelocytic leukemia, multiple myeloma, acute lymphoblastic leukemia (ALL), acute myeloid/myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). In more particular embodiments, the anti-WT1/A antibodies may comprise one or more framework region amino acid substitutions designed to improve protein stability, antibody binding and/or expression levels.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: January 10, 2017
    Assignees: MEMORIAL SLOAN KETTERING CANCER CENTER, EUREKA THERAPEUTICS, INC.
    Inventors: David Scheinberg, Tao Dao, Cheng Liu, Su Yan
  • Publication number: 20160280796
    Abstract: Disclosed herein is a bi-specific form of a T cell receptor mimic (TCRm) mAb with reactivity to human immune effector cell antigen and a WT1 peptide/HLA-A epitope. This antibody selectively bound to leukemias and solid tumor cells expressing WT1 and HLA-A as well as activated resting human T cells to release interferon-(IFN-?) and to kill the target cancer cells in vitro. Importantly, the antibody mediated autologous T cell proliferation and directed potent cytotoxicity against fresh ovarian cancer cells. Therapeutic activity in vivo of the antibody was demonstrated in NOD SCID SCID Yc* (NSG) mice with three different human cancers expressing WT1/HLA-A2 including disseminated Ph+ acute lymphocytic leukemia (ALL), disseminated acute myeloid leukemia, and peritoneal mesothelioma. In both of the leukemia xenograft models, mice that received the antibody and T cells also showed longer survival and delayed limb paralysis.
    Type: Application
    Filed: November 7, 2014
    Publication date: September 29, 2016
    Inventors: David Scheinberg, Jingyi Xiang, Tao Dao, Su Yan, Cheng Liu
  • Patent number: 9311290
    Abstract: According to one embodiment, a method is provided for approximate named-entity extraction from a dictionary that includes entries, where each of the entries includes one or more words. Words are read from the entries of the dictionary, and network resources are searched to determine a frequency of occurrence of the words on the network resources. In view of the frequency of occurrence of the words located on the network resources, domain relevancy of the words in the entries of the dictionary is determined. A domain repository is created using top-ranked words as determined by the domain relevancy of the words. In view of the domain repository, signatures for both the entries of the dictionary and strings of an input document are computed. The strings of the input document are filtered by comparing the signatures of the strings against the signatures of the entries to identify approximate-match entity names.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: April 12, 2016
    Assignee: International Business Machines Corporation
    Inventors: Ying Chen, William S. Spangler, Su Yan
  • Patent number: 9251133
    Abstract: According to one embodiment, approximate named-entity extraction from a dictionary that includes entries is provided, where each of the entries includes one or more words. Words are read from the entries of the dictionary, and network resources are searched to determine a frequency of occurrence of the words on the network resources. In view of the frequency of occurrence of the words located on the network resources, domain relevancy of the words in the entries of the dictionary is determined. A domain repository is created using top-ranked words as determined by the domain relevancy of the words. In view of the domain repository, signatures for both the entries of the dictionary and strings of an input document are computed. The strings of the input document are filtered by comparing the signatures of the strings against the signatures of the entries to identify approximate-match entity names.
    Type: Grant
    Filed: December 12, 2012
    Date of Patent: February 2, 2016
    Assignee: International Business Machines Corporation
    Inventors: Ying Chen, William S. Spangler, Su Yan
  • Publication number: 20150259436
    Abstract: The present invention provides antigen binding proteins that specifically bind to Wilms' tumor protein (WT1), including humanized, chimeric and fully human antibodies against WT1, antibody fragments, chimeric antigen receptors (CARs), fusion proteins, and conjugates thereof. The antigen binding proteins and antibodies bind to HLA-A0201-restricted WT1 peptide. Such antibodies, fragments, fusion proteins and conjugates thereof are useful for the treatment of WT1 associated cancers, including for example, breast cancer, ovarian cancer, prostate cancer, chronic myelocytic leukemia, multiple myeloma, acute lymphoblastic leukemia (ALL), acute myeloid/myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). In more particular embodiments, the anti-WT1/A antibodies may comprise one or more framework region amino acid substitutions designed to improve protein stability, antibody binding and/or expression levels.
    Type: Application
    Filed: May 28, 2015
    Publication date: September 17, 2015
    Applicants: Memorial Sloan Kettering Cancer Center, Eureka Therapeutics, Inc.
    Inventors: David Scheinberg, Tao Dao, Cheng Liu, Su Yan
  • Patent number: 9074000
    Abstract: The present invention provides antigen binding proteins that specifically bind to Wilms' tumor protein (WT1), including humanized, chimeric and fully human antibodies against WT1, antibody fragments, chimeric antigen receptors (CARs), fusion proteins, and conjugates thereof. The antigen binding proteins and antibodies bind to HLA-A0201-restricted WT1 peptide. Such antibodies, fragments, fusion proteins and conjugates thereof are useful for the treatment of WT1 associated cancers, including for example, breast cancer, ovarian cancer, prostate cancer, chronic myelocytic leukemia, multiple myeloma, acute lymphoblastic leukemia (ALL), acute myeloid/myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). In more particular embodiments, the anti-WT1/A antibodies may comprise one or more framework region amino acid substitutions designed to improve protein stability, antibody binding and/or expression levels.
    Type: Grant
    Filed: April 2, 2012
    Date of Patent: July 7, 2015
    Assignees: MEMORIAL SLOAN KETTERING CANCER CENTER, EUREKA THERAPEUTICS, INC.
    Inventors: David A. Scheinberg, Tao Dao, Cheng Liu, Su Yan
  • Patent number: 8927932
    Abstract: A scanning transmission electron microscope for imaging a specimen includes an electron beam source to generate an electron beam. Beam optics are provided to converge the electron beam. A stage is provided to hold a specimen in the path of the electron beam. A beam scanner scans the electron beam across the specimen. A controller may define one or more scanning areas corresponding to locations of the specimen, and control one or more of the beam scanner and stage to selectively scan the electron beam in the scanning areas. A detector is provided to detect electrons transmitted through the specimen to generate an image. The controller may generate a sub-image for each of the scanning areas, and stitch together the sub-images for the scanning areas to generate a stitched-together image. The controller may also analyze the stitched-together image to determine information regarding the specimen.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: January 6, 2015
    Assignee: Mochii, Inc.
    Inventors: Christopher Su-Yan Own, William Andregg, Michael Lee Andregg
  • Patent number: 8921787
    Abstract: A transmission electron microscope includes an electron beam source to generate an electron beam. Beam optics are provided to converge the electron beam. A specimen holder is provided to hold a specimen in the path of the electron beam. A detector is used to detect the electron beam transmitted through the specimen. The transmission electron microscope may be adapted to generate two or more images that are substantially incoherently related to one another, store the images, and combine amplitude signals at corresponding pixels of the respective images to improve a signal-to-noise ratio. Alternatively or in addition, the transmission electron microscope may be adapted to operate the specimen holder to move the specimen in relation to the beam optics during exposure or between exposures to operate the transmission electron microscope in an incoherent mode.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: December 30, 2014
    Assignee: Mochii, Inc.
    Inventors: Christopher Su-Yan Own, Andrew Bleloch, William Andregg
  • Publication number: 20140294841
    Abstract: The present invention provides antigen binding proteins that specifically bind to Wilms' tumor protein (WT1), including humanized, chimeric and fully human antibodies against WT1, antibody fragments, chimeric antigen receptors (CARs), fusion proteins, and conjugates thereof. The antigen binding proteins and antibodies bind to HLA-A0201-restricted WT1 peptide. Such antibodies, fragments, fusion proteins and conjugates thereof are useful for the treatment of WT1 associated cancers, including for example, breast cancer, ovarian cancer, prostate cancer, chronic myelocytic leukemia, multiple myeloma, acute lymphoblastic leukemia (ALL), acute myeloid/myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). In more particular embodiments, the anti-WT1/A antibodies may comprise one or more framework region amino acid substitutions designed to improve protein stability, antibody binding and/or expression levels.
    Type: Application
    Filed: April 2, 2012
    Publication date: October 2, 2014
    Applicants: EUREKA THERAPEUTICS, INC., MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: David A. Scheinberg, Tao Dao, Cheng Liu, Su Yan
  • Publication number: 20140284475
    Abstract: A transmission electron microscope includes an electron beam source to generate an electron beam. Beam optics are provided to converge the electron beam. A specimen holder is provided to hold a specimen in the path of the electron beam. A detector is used to detect the electron beam transmitted through the specimen. The transmission electron microscope may be adapted to generate two or more images that are substantially incoherently related to one another, store the images, and combine amplitude signals at corresponding pixels of the respective images to improve a signal-to-noise ratio. Alternatively or in addition, the transmission electron microscope may be adapted to operate the specimen holder to move the specimen in relation to the beam optics during exposure or between exposures to operate the transmission electron microscope in an incoherent mode.
    Type: Application
    Filed: April 21, 2014
    Publication date: September 25, 2014
    Applicant: Mochii, Inc. (d/b/a Voxa)
    Inventors: Christopher Su-Yan Own, Andrew Bleloch, William Andregg
  • Publication number: 20140163964
    Abstract: According to one embodiment, a method is provided for approximate named-entity extraction from a dictionary that includes entries, where each of the entries includes one or more words. Words are read from the entries of the dictionary, and network resources are searched to determine a frequency of occurrence of the words on the network resources. In view of the frequency of occurrence of the words located on the network resources, domain relevancy of the words in the entries of the dictionary is determined. A domain repository is created using top-ranked words as determined by the domain relevancy of the words. In view of the domain repository, signatures for both the entries of the dictionary and strings of an input document are computed. The strings of the input document are filtered by comparing the signatures of the strings against the signatures of the entries to identify approximate-match entity names.
    Type: Application
    Filed: August 20, 2013
    Publication date: June 12, 2014
    Applicant: International Business Machines Corporation
    Inventors: Ying Chen, William S. Spangler, Su Yan